Journal
ACS CHEMICAL NEUROSCIENCE
Volume 10, Issue 3, Pages 1127-1128Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.9b00034
Keywords
A beta hypothesis; Alzheimer's disease; disease-modifying therapy approach; multitarget small molecules; symptomatic-disease approach; tau hypothesis
Funding
- MINECO (Government of Spain) [SAF2015-65586-R]
- Universidad Camilo Jose Cela (NitroStroke project) [2015-12]
Ask authors/readers for more resources
Credit should be granted to medicinal chemists with a solid background in organic chemistry and computational chemistry, able to read, understand, and discuss the biological data, in order to design new and more efficient therapeutic approaches for Alzheimer's disease
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
